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Abstract
We have determined the framework structure of Myochrysine (disodium goid(I)thiomalate) in the
solid state and extremely concentrated aqueous solution, previously. It consists of an open chain polymer
with linear gold coordination to two thiolates from the thiomalic acid moieties which bridge between pairs
of gold atoms providing an Au-S-Au angle of 95 The question remained: was this structure relevant to
the dilute solutions of drugs administered and the still lower concentrations of gold found in the bodies of
patients (typically 1 ppm Au in blood and urine or 5 pM in Au). We have provided an answer to that
question using extended X-ray absorption spectroscopy (EXAFS) and capillary zone electrophoresis
(CZE). EXAFS studies confirm that the polymeric structure with two sulfur atoms per gold atom persists
from molar concentrations down to millimolar concentrations. CZE is able to separate and detect
Myochrysine at miilimolar levels. More importantly, at micromolar levels Myochrysine solutions exhibit
identical CZE behavior to that measured at millimolar levels. Thus, aqueous solutions of the drug remain
oligomeric at concentrations commensurate with those found in patient blood and urine.
The reactivity of Myochrysine with cyanide, a species especially prevalent in smoking patients,
was explored using CZE. Cyanide freely replaces thiomalic acid to form [Au(CN)2]" and thiomalic acid via
4 a mixed ligand intermediate. The overall apparent equilibrium constant (Kapo) for the reaction is 6x10 M-
Further reaction of [Au(CN)2]" with a large excess of L, where L i-cysteine, N-acetylcysteine, or
glutathione, shows that these amino acids readily replace cyanide to form [Aul.2]. These species are thus
potential metabolites and could possibly be active forms of gold in vivo. That all of these species are readily
separated and quantified using CZE demonstrates that capillary electrophoresis is an accessible and
powerful tool to add to those used for the study of gold-based antiarthritis drugs.
Introduction
The gold-based drugs used in rheumatoid arthritis therapy are extraordinary in that they have been
prescribed for 70 years or more while their mode of action is not yet understood. Also these drugs are
extremely labile, converting to a variety of biotransformation products once they are administered. Thus,
the active agent is unknown as well.
In this paper we attempt to deal with some of this uncertainty. We have previously examined the
structure of disodium gold(I)thiornalate (Myochrysine, AuTM) and found that it is oligomeric with sulfur
bridges between gold atoms forming a helical structure with an oligomerization number of approximately
six (1). The gold-sulfurframework structure is shown in Figure 1. This open chain structure is end capped
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by a seventh thiomalate iigand giving a ratio of Au:S of 6:7 (2).
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FIGURE 1: PROPOSED STRUCTURE OF MYOCHRYSINE. ONLY THE GOLD AND SULFUR ATOMS
ARE DISPLAYED FOR SIMPLICITY. THE SULFUR ATOMS ARE BOUND TO GOLD AND
FORM A 180 DEGREE ANGLE AND THE GOLD--SULFUR-G(D ANGLE IS 95 DEGREES.
THERE IS A 90 DEGREE TORSIONAL ANGLE ABOUT THE SULFUR-GOLD-SULFUR
LINKAGE THAT ALLOWS FOR THE CLOSE AU1-AU3 CONTACT SEEN IN THE
WAXS/DAS DATA.
We also had received from Drs. Helen Howard Lock and Colin Lock of McMaster University
samples of optically pure sodium gold(I) thiomalate. That is, samples synthesized using either the D-or
L-form of thiomalic acid as opposed to the enantiomeric mixture of the acids normally used in the synthesis
of AuTM. We wished to determine whether there were any differences between the optically pure forms
and the enantiomeric mixture which could be determined by EXAFS studies.
Also, we were concerned whether the drug structure, determined either with the solid drug or in
extremely concentrated solution, had any bearing on the drug as it exists after administration at typical
concentrations of a few parts per million gold (micmmolar concentrations) in the blood stream. To
determine whether the same structure persists at such low concentrations we have utilized a two part
strategy. First, we have examined the structure using extended X-ray absorption fine structure (EXAFS)
at millirnolar concentrations. Second, we have characterized the drug using capillary zone electrophoresis
at millimolar levels and also at the micromolar levels of gold which are found in patients’ blood. Details of
those studies are presented here.
Since we have recently found dicyanogoid(I) circulating in the blood and excreted in the urine of
patients receiving various gold drugs (3), we wished to see both how that complex might form and how
reactive it is, especially toward some of the thiols such as cysteine and glutathione which are naturally
available in the body. These reactions have been characterized using capillary zone electrophoresis as
well and the results presented here.
Materials and Methods
Reagents and Materials. Myochrysine (disodium gold(I) thiomalate) and thiomalic acid were purchased
from Aldrich Chemical Co. (Milwaukee, Wl), Potassium dicyanogold(I) was pumhased from Sigma (St.
Louis, MO) and Potassium cyanide was pumhased from Mallinckmdt Chemical Co.(St. Louis, MO). D and
L forms of Myochrysine were a gift from Drs. Colin and Helen Howard Lock of McMaster University. All
reagents were used without further purification except where noted.
Extended X-ray Absorption Fine Structure (EXAFS). Solid samples were prepared by diluting 10 mg
of each sample wilh 60 rng of f’rtely ground boron nitride and placed in a cell with a 1 mm path length and
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cross-section of 3 by 27 ram. Solution samples were made by dissolving the requisite mass of myochrysine
in 10 mL of water to make samples that were 3.06 and 5.03 mM. Approximately 0.1 mL of each solution
was loaded into separate cells with a 1 mm path length.
EXAFS data for solids were collected at SSRL beamline IV-3, whereas those for solutions were
measured at NSLS beamline X19A. Data collection methods were essentially the same for both beamlines
with the exception that the solution data were measured at room temperature and the solids at 10 K.
Transmitted and incident intensity were measured using standard nitrogen-filled ionization chambers.
Simultaneous calibration of the wavelength was performed by passing the transmitted intensity through
a gold foil standard. Fluorescence data were collected concurrently using a Stern, Heald detector fitted with
a gernnium filter to stop scattered radiation. Data were collected from 300 eV below the Au-L edge to
1040 eV above the Au-LI edge. A locally modified version of XFPAK (Robert Scott, University of Georgia)
was used to process the data.
Capillary Zone Electrophoresis. A Beckman P/ACE 2050 (Beckman, CA) with an on-line UV detector
at 214 nm was used for the electmphoresis studies. Pressure injections were used to introduce the sample
onto a 75 micrometer I.D. fused-silica capillary column (Polymicm Technologies, Phoenix, AZ). The total
length of the column is ca. 20 cm from injection point to detection point. Each new capillary was pretreated
with 0.1 M phosphoric acid for two hours and then flushed thoroughly with water, 20 mM sodium hydroxide
and finally the buffer solution. Prior to each injection the capillary was rinsed with 10 mM sodium hydroxide
and buffer solution. The capillaries were checked daily against a standard for reproducibility. Joule heating
was compensated for by cooling the capillary with a circulating coolant jacket which maintained the
temperature at 30.00+0.01 C.
Results
EXAFS of Solid and Solution Myochrysine. The pseudo radial distribution functions calculated from the
three solid samples: L, D, and racemic forms of AuTM are shown in Figure 2 and show no recognizable
differences from sample to sample. The principal peak near 1.9 , was back transformed in each case and
fit to model parameters taken from a solid sample of Na3[Au(S203)2]. The results were as follows: D-AuTM:
n=2.0, d=2.29 ,, DE=2.0 eV, sigma=0.052 , and Fit=0.20; L-AuTM: n=2.1, d=2.29 ., DE=I.7 eV,
sigrna---0.056 . and Fit=0.14; racemic-AuTM-n=1.8, d=2.30 , DE=0.3 eV, sigma=0.048 . and Fit=0.19,
where n is the coordination number, d is the bond distance, DE is the shift in Eo (the onset energy for
EXAFS), sigma is the disorder parameter and Fit is the goodness of fit to the model.
Solution data were measured for D-AuTM on a 3.06 mM solution and for L-AuTM on a 5.03 mM
solution. Previously we had measured a racemic-AuTM solution of 15.0 mM (1). Pseudo radial distribution
functions for 3.06, 5.03 and 15.0 mM aqueous solutions of D-, Land racemic-AuTM respectively contain
a single intense peak, indistinguishable from those shown in Figure 2. The peaks were transformed into
k space and modeled with empirical parameters extracted from the solid sample of Na3[Au(S203)2].
Coordination numbers calculated for the dilute solutions (2.1 atoms for 3 mM D Myochrysine and 2.1 atoms
for 5 mM L Myochrysine) are in excellent agreement for those calculated for the corresponding solid
samples (2.0 and 2.1 atoms respectively). Although coordination numbers from EXAFS have large errors
associated, these values are well within the generally accepted limits for a two coordinate species.
Solution bond distances are 2.31 A for both the D and L forms and 2.30 A for the mcemic form (4).
Differences of 0.01 A are statistically insignificant for bond distance calculations and therefore the
distances calculated for all of the above samples are considered the same.
CZE of Low Concentration Aqueous Solutions of Myochrysine. Capillary zone electrophomsis is a
conceptually simple experiment in which a buffer-filled, open silica capillary column is placed between two
electrolyte reservoirs as indicated in Figure 3. Sample is introduced into the capillary by hydrostatic
pressure or electromigration. After1he capillary is placed in the electrolyte a potential difference is applied
across the capillary. Separation of molecules and ions using CZE is based on their charge densities.
Conventional CZE operates with the detector near the cathode and the sample is injected at the anodic
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end. In this arrangement cations are moved rapidly toward the detector by electrophoresis while neutral
and anionic species migrate more slowly based on electmosmotic flow (EOF). Subtle differences in the
charge orvolume of the molecule will change the electromigration time (5). Thus a change in composition
of Myochrysine as a function of concentration will result in a shifting of the corresponding peak in the
electrophemgram. Electrophemgrams of AuTM solutions are shown in Figure 4. Individual components
may be identified by their retention times or with a diode array spectrometer as detector by their spectra.
For the electrophemgram shown in Figure 4, the separation between the injection point and the variable
wavelength detector operated at 214 nm was 20 cm. A 20 mM phosphate buffer at pH 8.0 was used with
a potential difference of 8 kV.
(a) Racemic Myochrysine
(b) D-yochrysine
(c) L-yochrysine
0.0 3.0 6.0
FIGURE 2 COMPARISON OF THE PSEUDO RADIAL DISTRIBUTION FUNCTIONS FORTHE D, L,O
RACEMIC FORMS OF MYOCHRYSINE IN THE SOLID PHASE. THE PEAK SHOWN IS THE
GOLD-SULFUR PEAK. NO PEAK CORRESPONDING TO A GOLD-GOLD INTERACTION IS
PRESENT. THE PRDF’s ARE VIRTUALLY IDENTICAL AND SHOW NO DIFFERENCES IN
STRUCTURE.
FIGURE 3. SCHEMATIC DIAGRAM OF CAPILLAW ELECTROPHORESlS INSTRUMENT.
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FIGURE 4. COMPARISON OFTHE ELECTROPHEROGRAMS OF (UPPER TRACE) 5pM AND (BOTTOM
TRACE) 1 MM MYOCHRYSINE IN 20 MM PHOSPHATE BUFFER, PH 8.
Myochrysine was dissolved at various concentrations ranging from millimolar as was used for the
EXAFS studies to the micmmolar gold concentrations found in patient’s blood and urine. The solvent was
20 mM sodium phosphate buffer adjusted to pH=8.0 using phosphoric acid and sodium hydroxide. With
careful control of column pretreatment and rinsing, migration times are highly reproducible. Thus for 10
samples of AuTM, the average migration time was 8.61 min with a standard deviation of 0.14 min or a
relative standard deviation of 1.6%. Peak shape and electromigration time in the electrophemgrams are
identical at both millimolar and micromolar concentrations of AuTM (see Figure 4).
Solution Studies of Myochrysine and Cyanide. Our previous studies of patients undergoing AuTM
therapy show that dicyanogold(I) is a major metabolite, accounting for as much as 30% of the excreted
gold (3) which appears in urine. Some free dicyanogold(I) is found in the blood as well. Cyanide is inhaled
from cigarette smoke in the form of hydrocyanic acid and also occurs naturally as a product of the oxidative
burst of polymorphonuclear leukocytes (6). Once injected into a patient, AuTM can undergo ligand
exchange reactions with free cyanide which may hinder, modify or enhance its therapeutic properties.
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Graham et al. followed the reaction of potassium cyanide and Myochrysine using 13C andH NMR
techniques. They concluded that dicyanogold(I) was formed via a mixed ligand intermediate which
maximized at a 1:1 molar ratio of cyanide to Myochrysine. Because of severe line broadening and overlap
of signals at a ratio higher than 2:1 cyanide to Myochrysine they were not able to study larger ratios. Due
to the relative insensitivity of NMR, they were unable to follow reactions at physiological levels and instead
used concentrations at millimolar levels (20 mM for C NMR). We were able to follow the same reaction at
a ratio up to 10:1 cyanide to Myochrysine using CZE with UV detection at 214 nm and determine an.overall
equilibrium constant.
Initially myochrysine, thiomalic acid and dicyanogold(I) were individually separated using CZE to
determine the optimum conditions for elution. Applied voltage, pH and reproducibility were systematically
studied to determine the best conditions for separation. Linear calibration curves of absorbance vs. log
concentration were calculated for use in determining the equilibrium constants.
Reaction: Au-tm + KCN
a. KCNIAuqm 1.5
Au-tm
c
Au(CN) 2" :--22--
FIGURE 5
b. KCN/Au-tm 3
:: Au(CN) 2"
tmN
ELECTROPHEF:E)GRAMSOF REACTION MIXTUREOFAuTM WITH KCN 27 C,M CAPILLARY; 8 KV;
214 NM; 20 MM PHOSPHATE, PH 8.0
Myochrysine was dissolved in 20 mM aqueous phosphate buffer to make a 1.0 mM solution. The
PH was adjusted to 8.0 with phosphoric acid and sodium hydroxide. Aliquots were taken at the initial
concentration and at regular intervals as the solution was titrated with KCN. After the first addition of KCN
three peaks in the electmphemgram corresponding to AuTM, dicyanogold(I) and a mixed ligand species
were separated (see Rgure 5). As the concentration of cyanide was increased to 2:1 cyanide to AuTM the
concentrations of mixed rgand species and dicyanogold( ) increased and the gold thiomalate decreased.
Add KCN caused a continued decrease in the concentration of AuTM and the mixed ligand species
also began to decrease. AuTM was completely converted to the mixed ligand species and dicyanogold(I)
at a ratio of 3:1 KCN to AuTM. Dicyanogold(I) was the only species left in solution after a ratio of 4:1
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cyanide to Myochrysine was reached. These results, presented in Figure 6, clearly show that AuTM is
converted to dicyanogold( via a mixed ligand intermediate supporting the earlier NMR work done by
Graham. The small discrepancy in the maximum formation of the mixed ligand intermediate may be
attributable to the difference in buffer concentrations used for the CZE and NMR experiments. High buffer
concentrations in CZE cause high voltage leakage problems thereby forcing us to use a much lower buffer
concentration than used in the NMR experiments.
0.6
0.4
0.2
0
0
Autm
2
Inil:ial CN’/Au-t,m Pio
cl’,r]
4 6 8 i0
FIGURE 6 TITRATION OFAuTM WITH KCN. 27 CM FUSED-SILICA CAPILLARY COLUMN; 8 KV;
20 MM PHOSPHATE BUFFERE, PH 7.4. [(TM-AU-CN)’] WAS CALCULATED FROM
THE DIFFERENCE BETWEEN TOTAL GOLD CONCENTRATION AND MEASURED
CONCENTRATIONS OF AUTM AND [AU(CN)2]’.
The equilibrium constant was calculated according to:
1/n [AuTM]n +[CN]"--KI--> [TMAuCN] (1)
[TMAuCN + [CN]"--K2--> [Au(CN)2]" + TM (2)
The overall equilibrium constant Kapp is defined as:
Kapp K K2= ([Au(CN)2 [TM]/([AuTM] [(CN)’]2) = 0.0006 M"1 (3)
The equilibrium constant K2 was most easily measured by studying the reverse reaction, that of thiomalic
acid with dicyanogold(I). Figure 7 shows that reaction where the broad peak in the electropherogram
occurring at ca. 21.5 min is clearly indicated to be the mixed ligand species [TMAuCN]’. Details of the
measurements and calculations are available in the dissertation of Z. Zhao (5).
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Identiication of [Auntmp]
a. Au-tm Ch r l" 1.5
0
Au-tm
[tm-Au-CN]"
[Au(C
b. Au-tm" tnz[-I i’I
tm" Au-tm
[AUntmp]
"p/n
O.O0 O.O0 20. O0
FIGURE 8 COMPARISON OF REACTIN OF (TOP) AuTM + KCN AND (BOTI’OM)
AuTM + TMH.
Dicyanogold(l), bis(cysteinato)gold(I) and cysteine calibration curves for absorbance vs. log
concentration were calculated. A solution of dicyanogold(I), 1.0 mMg buffered to a pH of 7.4 with
phosphate was titrated with cysteine and followed with CZE as shown in Figure 9. At a 1:1 ratio of
dicyanogold(I) to cysteine four peaks were present in the electrophemgram. Two peaks are attributed to
cysteine and dicyanogold(I) and the two others are presumed to be bis(cysteinato)gold(I) and a mixed
gold(I) species containing cyanide and cysteine. No dicyanogold(I) was left after a ratio of 1:100
dicyanogold(I) to cysteine was reached and only a trace amount of the mixed ligand species was present.
The equilibrium constant was calculated as follows:
[Au(CN)2]" + cys --K--> [cysAuCN]" + CN"
[cysAuCN]" + cys -K2--> [Au (cys)2]" + CN"
K=q = KI* K2([Au(cys)2 [CN" ]2) / ([Au(CN)2]- [cys]2) = 0.006
(s)
(6)
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Solution studies of [Au(CN)2]" and N-acetylcysteine. These were very similar in appearance to those
with cysteine. Four peaks were apparent in the electropherogram. No equilibrium concentration
measurements were attempted for this system.
..
o o.
[Au(CN) 2]" C
[Au(CN) 2]" Cysteine 1 1
[Au(CN) 2]"
o Cys [Au(CN) 2]" Cysteine 10
B
[Au(CN) 2]
o Cys
D .c oo. [Au(CN) 2]" Cysteine 100
t
FIGURE 9 ELECTROPHEROGRAMS OF 1.0 MM [Au(CN)2]" (A), MIXTURES OF [AU(CN)2]"
WITH CYSTEINE AT THE RATIOS OF [AU(CN)2]’/CYSTEINE 1 (B), [AU(CN)2]"
/CYSTEINE = 1/10 (C) AND [Au(CN)2]’/CYSTEINE 1/100 (O)IN 20 MM
PHOSPHATE BUFFER, PH 7.4.
Solution Studies of [Au(CN)2]" and Glutathione. Glutathione (GSH) is present in high concentrations
inside cells and has a high binding affinity for gold(I). Because of the similarity to cysteine, we expected
dicyanogold(I) to react with glutathione via a mixed ligand intermediate. Interestingly this is not observed.
Reaction of dicyanogold(I) and GSH in 2:1 and 1 "1 ratios showed that dicyanogold(I) is converted directly
to [Au(GSH)2]and no evidence for a mixed ligand species was present as can be seen in Figure 10. A
product with the same migration time was also seen in the reaction of AuTM with GSH, ruling out the
possibility that this peak is due to a CN" containing mixed ligand species. This failure to observe a mixed
ligand species also is in agreement with the earlier 13C NMR study of Lewis and Shaw (8). The pathway
for this reaction has not yet been determined.
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dentification of [tm-Au-C,N-]"
Au-tm / CN" [Au(CN)2]" [tm-Au-CN’]" + tin"
[Au(CN)2]"
Reaction: [Au(CN)=]" + tm" [tm-Au-CN]’+
[tm-Au-CN]"
FIGURE 7 COMPARISON OF THE REACTION OF (TOP) AuTM + KCN AND (BOTTOM)
[AU(CN)2]" + tmH.
Solution Studies of AuTM and Thiomalic Acid. In order to observe the effect of added thiomalate on
Myochwsine, solution studies in parallel to those earlier ones of Isab and Sadler (7) were undertaken using
CZE. The electmpherogram obtained is shown in Figure 8.
Solution studies of [Au(CN)2] and Cysteine. Biological fluids contain many species which bind gold(I)
readily and compete with CN-. Thiol containing amino acids have a high affinity to bind gold(I) and are
readily available in the blood stream. Two of the most abundant, cysteine (cys) and glutathione (GSH)
were studied using CZE and the equilibrium constant for reaction of dicyanogold(I) and cysteine was
calculated.
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GSH
[Au(CN)2]"
[Au(GSH)2]"
FIGURE 10 MIXTURE OF [AU(CN)2]" AND GLUTATHIONE.
Discussion
Structure of Myochrysine in Solution. The EXAFS experiments reported here show that the polymeric
structure (previously discovered, using rather esoteric WAXS and DAS experiments) of AuTM (see Figure
1) is maintained at millimolar concentrations. The CZE experiments demonstrate that this same structure
persists from millimolar to micmmolar levels, such as those seen in the blood and urine of patients on
chrysotherapy. Of course, these studies were performed in the absence of the additional endogenous
thiols found in the human body, such as cys-34 of albumin, free cysteine or glutathione, which may break
up the polymer in vivo. However, they do show that the AuTM (and presumably gold(I)thioglucose or
Solganol) polymers are quite robust.
Additionally, these studies provide some information that the D- and L-forms of AuTM are no
different from the racemic form used in chrysotherapy, in terms of their framework structure. Clearly more
subtle differences with respect to in vivo interactions with chiral materials in the body are possible.
Reactions of AuTM with Cyanide and Thiomalic acid. Here CZE experiments with UV detection show
that the reactions of KCN with AuTM produce a mixed ligand peak at ca. 21.5 min. Figures 5 and 7 (the
latter produced via the reverse reaction of [Au(CN)2]" with thiomalate) clearly demonstrate that this reaction
produces a mixed ligand species corresponding to [TMAuCN]’.
Interestingly, F’gures 8a and 8b both show mixed oligomeric complexes of the type [AUnTMI "p+n.
It appears that the broad unresolved "blobs" which rise in both electropherograms originate from these
polynuclear species in which the ratio of p to n is greater than 7 to 6. The lack of resolution in the
separation of these materials suggests that they are a rapidly reequilibrating mixture with slightly different
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electropheretic behaviors for the individual components. The strikingly different behavior for "AuTM" (the
sharp, well-defined peak at slightly less than 10 min) suggests a much greater stability for that particular
species.
Reactions of [Au(CN)2]" with Thiols. Clearly these reactions are not all of the same pattern. While
cysteine and N-acetylcysteine require large excesses of thiol to force the reaction to completion and show
evidence of a stable mixed ligand complex with one cyanide and one thiolate ligand, glutathione does not.
The glutathione reaction requires less of an excess of the ligand and shows no evidence of a mixed ligand
complex. Given the added steric bulk of this ligand compared to cysteine, it may be that some ligand-ligand
interaction for bis(glutathione)gold(I) stabilizes the complex relative to other bis(thiolato)gold(I) complexes.
Finally, it is worth mention that, CZE is a powerful technique for the separation of metal complexes.
Its utility for separation and characterization of metal-based drugs and metabolites has been demonstrated
here.
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